1353 Pill - pink oval
Pill with imprint 1353 is Pink, Oval and has been identified as Tofacitinib Citrate Extended-Release 11 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Tofacitinib is used in the treatment of Ankylosing Spondylitis; Rheumatoid Arthritis; Psoriatic Arthritis; Ulcerative Colitis; Polyarticular Juvenile Idiopathic Arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Tofacitinib 11 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1353
Tofacitinib Citrate Extended-Release
- Imprint
- 1353
- Strength
- 11 mg
- Color
- Pink (light pink to pink)
- Shape
- Oval (film-coated)
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Zydus Lifesciences Limited
- National Drug Code (NDC)
- 70710-1353
Related images for "1353"
More about tofacitinib
- Check interactions
- Compare alternatives
- Reviews (172)
- Imprints, shape & color data
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.